KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Non-Current Deffered Revenue (2018 - 2024)

BioNTech SE's Non-Current Deffered Revenue history spans 7 years, with the latest figure at $195.6 million for Q4 2024.

  • On a quarterly basis, Non-Current Deffered Revenue fell 54.39% to $195.6 million in Q4 2024 year-over-year; TTM through Dec 2024 was $195.6 million, a 54.39% decrease, with the full-year FY2024 number at $195.6 million, down 54.39% from a year prior.
  • Non-Current Deffered Revenue hit $195.6 million in Q4 2024 for BioNTech SE, down from $428.8 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for BNTX hit a ceiling of $428.8 million in Q4 2023 and a floor of $10.3 million in Q4 2021.
  • Historically, Non-Current Deffered Revenue has averaged $153.9 million across 5 years, with a median of $85.7 million in 2020.
  • Biggest five-year swings in Non-Current Deffered Revenue: crashed 87.99% in 2021 and later soared 768.29% in 2023.
  • Tracing BNTX's Non-Current Deffered Revenue over 5 years: stood at $85.7 million in 2020, then tumbled by 87.99% to $10.3 million in 2021, then surged by 379.62% to $49.4 million in 2022, then soared by 768.29% to $428.8 million in 2023, then crashed by 54.39% to $195.6 million in 2024.
  • Business Quant data shows Non-Current Deffered Revenue for BNTX at $195.6 million in Q4 2024, $428.8 million in Q4 2023, and $49.4 million in Q4 2022.